Riskpilot← Back to searchSign inGet full accessBiosense Solutions ApS
APSActiveCVR 38602926Hirsemarken 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 201713 employees
Revenue 2025
DKK 4,9M
+65% vs 2024
EBITDA margin
17.7%
+217% vs 2024
Equity ratio
33.3%
Financial strength
Net profit 2025
DKK 714K
+210% vs 2024
| Revenue | DKK 4,9M | +65% |
| EBITDA | DKK 866K | +217% |
| Net profit | DKK 714K | +210% |
| Total assets | DKK 3,8M | +22% |
| Equity | DKK 1,3M | +129% |
| Employees | 13 | — |
Legal name
Biosense Solutions ApS
CVR number
38602926
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28. april 2017
Share capital
DKK 113.636
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør, eller af to bestyrelsesmedlemmer i forening, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive udviklings- og produktionsvirksomhed af elektroniske produkter.
Address
Hirsemarken 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 304 | 1.637 | 2.101 | 2.554 | 2.778 | 3.244 | 4.210 | 2.966 | 4.888 |
| Staff expenses | -404 | -1.384 | -1.979 | -2.192 | -2.816 | -3.159 | -3.486 | -3.707 | -4.021 |
| EBITDA | -100 | 252 | 122 | 362 | -39 | 84 | 724 | -741 | 866 |
| Depreciation & amort. | -1 | -9 | -10 | -10 | -10 | -10 | -4 | -17 | -22 |
| EBIT | -101 | 244 | 112 | 352 | -49 | 74 | 720 | -758 | 844 |
| Net financials | -19 | -50 | -40 | -57 | -52 | -83 | -88 | -80 | -130 |
| Profit before tax | -121 | 194 | 72 | 295 | -101 | -9 | 632 | -838 | 714 |
| Tax | -0 | 19 | 17 | 68 | -1 | -0 | -0 | -190 | -0 |
| Net profit | -121 | 175 | 55 | 227 | -100 | -9 | 632 | -648 | 714 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 776 | 1.166 | 1.325 | 2.215 | 2.245 | 2.205 | 4.001 | 3.104 | 3.799 |
| Equity | -21 | 154 | 209 | 437 | 337 | 568 | 1.200 | 552 | 1.266 |
| Long-term debt | 0 | 0 | 43 | 736 | 1.023 | 930 | 1.710 | 1.496 | 1.586 |
| Short-term debt | 797 | 1.011 | 1.072 | 1.042 | 885 | 707 | 1.091 | 1.056 | 947 |
| Total debt | 797 | 1.011 | 1.114 | 1.778 | 1.908 | 1.637 | 2.801 | 2.553 | 2.533 |
EBITDA margin
17.7%
This company
15.8%
Market median
+12% vs market
20172025
Equity ratio
33.3%
This company
38.2%
Market median
+13% vs market
20172025
Return on equity
56.4%
This company
18.4%
Market median
+207% vs market
20172025
Net profit margin
14.6%
This company
8.1%
Market median
+80% vs market
20172025
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20172025
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
20172025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-04-28 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SB Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Famole G2 Holding ApS | Company | 33.3% | 33.3% | 2023 |
Spillum Holding ApS | Company | 25.0% | 25.0% | 2023 |
BUDA ApS | Company | 15.0% | 15.0% | 2024 |
| Individual | 15.0% | 15.0% | 2017 | |
| Individual | 10.0% | 10.0% | 2023 | |
FASTFLOW SYSTEMS ApS | Company | 10.0% | 10.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Spillum Holding ApS
Biosense Solutions ApS Board members of Biosense Solutions ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Busch | Management | 0 companies |
| Tom Olesen | Board of Directors | 0 companies |
| Jesper Bryde-Jacobsen | Board of Directors | 0 companies |
| Ole Nørgaard | Chairman | 0 companies |
| Erik Spillum | Board of Directors | 0 companies |
| Niels Stampe Rüdiger | Board of Directors | 0 companies |